Late Onset Parkinson's Disease in Subjects 70 Years and Older: Possible Use of Rotigotine
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
Price : $35 *
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms PARROT
- 02 Sep 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 29 May 2015 According to the ClinicalTrials.gov record, status changed from recruiting to suspended.
- 15 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.